Pilot study examining the frequency of several gene polymorphisms in a morbidly obese population

Obesity Surgery

Volumn 12, Issue 6, 2002, Pages 759-764

  Koumanis, Dimitri J ^a   Christou, Nicolas V ^a   Wang, Xiao Ling ^a   Gilfix, Brian M ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Diabetes; Gene polymorphisms; Genotyping; Lipid metabolism; Morbid obesity

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; CELL DNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SCAVENGER RECEPTOR;

ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DNA POLYMORPHISM; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MORBID OBESITY; MUTATION RATE; PILOT STUDY; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL;

ANTIGENS, CD36; CASE-CONTROL STUDIES; GENE FREQUENCY; HUMANS; MEMBRANE PROTEINS; OBESITY, MORBID; PILOT PROJECTS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-3; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LIPOPROTEIN; RECEPTORS, SCAVENGER; SCAVENGER RECEPTORS, CLASS B; TRANSCRIPTION FACTORS;

EID: 0036966349     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/096089202320995529     Document Type: Article

References (26)

1. Calle EE, Thun MJ, Petrelli JM et al. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999; 341: 1097-105.
2. Hirsch J, Leibel RL. The genetics of obesity. Hospital Practice 1998; 33(3): 55-77.
3. Maclean LD, Rhode BM. Does genetic predisposition influence surgical results of operations for obesity? Obes Surg 1996; 6: 132-7.
4. Rosenbaum M, Leibel RL, Hirsch J. Obesity. N Engl J Med 1998; 337: 396-407 [Erratum, N Engl J Med 1998; 338: 555]
5. Carlsson B, Lindel K, Gabrielssom B et al. Obese (ob) gene defects are rare in human obesity. Obes Res 1997; 5: 30-5.
6. Vaisse C, Clement K, Guy-Grand B et al. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet 1998; 20: 113-4.
7. Yeo GSH, Farooqi IS, Aminian S et al. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet 1998; 20: 111-2.
8. Xiong W, Grey JD. The roles of receptor abnormalities in the pathogenesis and chronic complications of type 2 diabetes. Clin Invest Med 1999; 22(3): 85-105.
9. Susuliv VS, Frederich RC, Lawitts J et al. Targeted disruption of the beta 3-adrenergic receptor gene. J Biol Chem 1995; 270: 29483-92.
10. Walston J, Silver K, Bogardus C et al. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta-3-andrenergic receptor gene. N Engl J Med 1995; 333: 343-7.
11. Widen E, Lehto M, Kanninen T et al. Association of a polymorphism in the beta 3-adrenergic receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 1995; 333: 348-51.
12. Clement K, Vaisse C, Manning BS et al. Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 1995; 333: 352-4.
13. Sakane N, Yoshida T, Umekawa T et al. Effects of Trp64Arg mutation in the 133-adrenergic receptor gene on weight loss, body fat distribution, glycemic control, and insulin resistance in obese type 2 diabetic patients. Diab Care 1997; 20: 1887-90.
14. Staels B, Dallongeville J, Auwerx J et al. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 1998; 98: 2088-93.
15. Kliewer SA, Lehmann JM, Willson TM. Orphan nuclear receptors; shifting endocrinology into reverse. Science 1999; 284: 757-60.
16. Ristow M, Muller-Wieland D, Pfeiffer A et al. Obesity associated with a mutation in the genetic regulator of adipocyte differentiation. N Engl J Med 1998; 339: 953-9.
17. Deeb SS, Fajas L, Nemoto M et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 1998; 3: 284-7.
18. Acton S, Osgood D, Donoghue M et al. Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population. Arterioscler Thromb Vasc Biol 1999; 19: 1734-43.
19. Murao K, Terpstra V, Green SR et al. Characterization of CLA-1, a human homologue of rodent scavenger receptor BI, as a receptor for high density lipoprotein and apoptotic thymocytes. J Biol Chem 1997; 272: 17551-7.
20. Kozarsky KF, Donahee MH, Rigotti A et al. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature 1997; 387(6631): 414-7
21. Rigotti A, Trigatti BL, Penman M et al. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci USA 1997; 94: 12610-5.
22. Wang N, Weng W, Breslow JL et al. Scavenger receptor BI (SR-BI) is up-regulated in adrenal gland in apolipoprotein A-I and hepatic lipase knock-out mice as a response to depletion of cholesterol stores. In vivo evidence that SR-BI is a functional high density lipoprotein receptor under feedback control. J Biol Chem 1996; 271: 21001-4.
23. Peeke PM, Chrousos GP. Hypercortisolism and obesity. Ann N Y Acad Sci. 1995; 771: 665-76.
24. Kersten S, Seydoux J, Petes JM et al. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 1999; 103: 1489-98.
25. Acton S, Rigotti A, Landschulz KT et al. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996; 271(5248): 518-20.
26. Clement K, Ruiz J, Cassard-Doulcier AM et al. Additive effect of A→G (-3826) variant of the uncoupling protein gene and the Trp64Arg mutation of the beta 3-adrenergic receptor gene on weight gain in morbid obesity. Int J Obes 1996; 12: 1062-6.